BR112012008238A2 - métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais. - Google Patents
métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais.Info
- Publication number
- BR112012008238A2 BR112012008238A2 BR112012008238A BR112012008238A BR112012008238A2 BR 112012008238 A2 BR112012008238 A2 BR 112012008238A2 BR 112012008238 A BR112012008238 A BR 112012008238A BR 112012008238 A BR112012008238 A BR 112012008238A BR 112012008238 A2 BR112012008238 A2 BR 112012008238A2
- Authority
- BR
- Brazil
- Prior art keywords
- animals
- methods
- muscle atrophy
- preventing
- treating sarcopenia
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 4
- 206010028289 Muscle atrophy Diseases 0.000 title abstract 3
- 230000020763 muscle atrophy Effects 0.000 title abstract 3
- 201000000585 muscular atrophy Diseases 0.000 title abstract 3
- 208000001076 sarcopenia Diseases 0.000 title abstract 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
- 150000002515 isoflavone derivatives Chemical class 0.000 abstract 1
- 235000008696 isoflavones Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
Abstract
patente de invenção: método para prevenção ou tratamento de sarcopenia e atrofia muscular em animais. a presente invenção refere-se a métodos para uma ou mais dentre prevenção ou tratamento de sarcopenia e atrofia muscular em animais. os métodos compreendem administrar isoflavonas aos animais, preferivelmente em quantidades de cerca de 0,001 a cerca de 10g/kg/dia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27863309P | 2009-10-09 | 2009-10-09 | |
PCT/US2010/002722 WO2011043827A1 (en) | 2009-10-09 | 2010-10-08 | Methods for preventing or treating sarcopenia and muscle atrophy in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012008238A2 true BR112012008238A2 (pt) | 2017-06-06 |
Family
ID=43857050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012008238A BR112012008238A2 (pt) | 2009-10-09 | 2010-10-08 | métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais. |
Country Status (12)
Country | Link |
---|---|
US (1) | US9301941B2 (pt) |
EP (1) | EP2485740B1 (pt) |
JP (1) | JP6122638B2 (pt) |
CN (1) | CN102573857A (pt) |
AU (1) | AU2010303872B2 (pt) |
BR (1) | BR112012008238A2 (pt) |
CA (1) | CA2776950C (pt) |
ES (1) | ES2688447T3 (pt) |
IN (1) | IN2012DN02624A (pt) |
MX (1) | MX2012004118A (pt) |
RU (1) | RU2558534C2 (pt) |
WO (1) | WO2011043827A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
CN104080454B (zh) * | 2011-06-06 | 2017-02-15 | 爱荷华大学研究基金会 | 用于抑制肌萎缩的方法 |
WO2013058579A1 (ko) * | 2011-10-18 | 2013-04-25 | (주)아모레퍼시픽 | 시링가레시놀을 포함하는 sirt 1 활성화제 |
CA2946825C (en) * | 2014-04-28 | 2022-08-23 | Suntory Holdings Limited | Muscle atrophy inhibitor containing quercetin glycoside |
CA2975217C (en) | 2015-02-13 | 2023-08-15 | Mars, Incorporated | Pet food feeding system |
KR20170002846A (ko) | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | 콩잎 추출물을 유효성분으로 함유하는 근질환 억제 및 예방용 조성물 |
GB201522304D0 (en) | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
CN108635571B (zh) * | 2018-07-19 | 2021-10-22 | 西安交通大学医学院第一附属医院 | 鸢尾素(irisin)在制备预防及治疗重症急性胰腺炎药物中的应用 |
WO2021065661A1 (ja) * | 2019-10-04 | 2021-04-08 | サントリーホールディングス株式会社 | 筋肉量の低下抑制、低下予防、維持、回復又は増加用組成物 |
KR102623198B1 (ko) * | 2020-02-26 | 2024-01-10 | 한국 한의학 연구원 | 돌콩 추출물을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소의 예방, 개선 또는 치료용 조성물 |
RU2756154C1 (ru) * | 2020-11-13 | 2021-09-28 | Митхат Зульфугар-Оглы Гасанов | Способ диагностики саркопении у пациентов с хронической болезнью почек 5д стадии, получающих лечение программным гемодиализом |
WO2023140407A1 (ko) * | 2022-01-21 | 2023-07-27 | 경상국립대학교병원 | 쿠메스트롤을 포함하는 근감소증 예방 또는 치료용 약학 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU166380B (pt) * | 1973-07-09 | 1975-03-28 | ||
US6887499B2 (en) * | 2000-05-22 | 2005-05-03 | Enitan A. Bababunmi | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
EP1192943A3 (en) * | 2000-09-28 | 2002-11-27 | Pfizer Products Inc. | Use of growth hormone secretagogues in conjunction with physical exercise |
AUPR846401A0 (en) * | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
JP5384777B2 (ja) * | 2001-12-18 | 2014-01-08 | 有限会社大長企画 | 強筋肉剤、抗炎症剤 |
US20070185012A1 (en) * | 2003-07-10 | 2007-08-09 | Rajadhyaksha V J | Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
CA2553814A1 (en) * | 2004-01-29 | 2005-08-11 | Elixir Pharmaceuticals, Inc. | Treating a viral disorder |
WO2005089567A1 (en) * | 2004-03-17 | 2005-09-29 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
JP2009537582A (ja) * | 2006-05-24 | 2009-10-29 | ディーエスエム アイピー アセッツ ビー.ブイ. | 有機化合物の新しい用途 |
CN103251579B (zh) * | 2006-08-24 | 2016-12-28 | 田纳西大学研究基金会 | 取代的n-酰基苯胺及其使用方法 |
-
2010
- 2010-10-08 MX MX2012004118A patent/MX2012004118A/es active IP Right Grant
- 2010-10-08 WO PCT/US2010/002722 patent/WO2011043827A1/en active Application Filing
- 2010-10-08 CA CA2776950A patent/CA2776950C/en active Active
- 2010-10-08 BR BR112012008238A patent/BR112012008238A2/pt not_active Application Discontinuation
- 2010-10-08 RU RU2012118686/13A patent/RU2558534C2/ru not_active IP Right Cessation
- 2010-10-08 EP EP10822363.7A patent/EP2485740B1/en active Active
- 2010-10-08 ES ES10822363.7T patent/ES2688447T3/es active Active
- 2010-10-08 IN IN2624DEN2012 patent/IN2012DN02624A/en unknown
- 2010-10-08 CN CN2010800446421A patent/CN102573857A/zh active Pending
- 2010-10-08 JP JP2012533139A patent/JP6122638B2/ja active Active
- 2010-10-08 US US13/499,118 patent/US9301941B2/en active Active
- 2010-10-08 AU AU2010303872A patent/AU2010303872B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20120238515A1 (en) | 2012-09-20 |
ES2688447T3 (es) | 2018-11-02 |
US9301941B2 (en) | 2016-04-05 |
JP2013507361A (ja) | 2013-03-04 |
WO2011043827A1 (en) | 2011-04-14 |
RU2012118686A (ru) | 2013-11-20 |
AU2010303872A1 (en) | 2012-04-19 |
EP2485740A1 (en) | 2012-08-15 |
CA2776950C (en) | 2023-11-21 |
JP6122638B2 (ja) | 2017-04-26 |
EP2485740B1 (en) | 2018-08-29 |
IN2012DN02624A (pt) | 2015-05-22 |
CN102573857A (zh) | 2012-07-11 |
CA2776950A1 (en) | 2011-04-14 |
MX2012004118A (es) | 2012-05-08 |
RU2558534C2 (ru) | 2015-08-10 |
EP2485740A4 (en) | 2013-04-03 |
AU2010303872B2 (en) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012008238A2 (pt) | métodos para prevenção ou tratamento de sarcopenia e atrofia muscular em animais. | |
WO2018084531A3 (ko) | 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물 | |
EA201370208A1 (ru) | Формы рифаксимина и их применение | |
MX2012000034A (es) | Metodos para el tratamiento o la prevencion de la fatiga. | |
EA201000603A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ | |
BR112016029713A2 (pt) | métodos para o tratamento de sobrepeso ou obesidade | |
AR065033A1 (es) | Metodos para prevenir y tratar trastornos neurodegenerativos | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EP2294184A4 (en) | TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY | |
DK1970059T3 (da) | Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser | |
MX2019014418A (es) | Uso de bacterias del ácido láctico para tratar o prevenir al menos una de depresión puerperal y ansiedad puerperal. | |
MX2010004074A (es) | Combinacion 059. | |
BR112013013429A2 (pt) | composição, método de prevenção ou tratamento de distúrbio ou doença de controle da respiração, e, método de prevenção de desestabilização ou estabilização do ritmo respiratório | |
WO2008016643A3 (en) | Certain chemical entities, compositions, and methods | |
GB2503852A (en) | Compounds for the treatment of neuropsychiatric disorders | |
MX2015013275A (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevencion de enfermedades o afecciones asociadas con difucion mitocondrial. | |
MY147247A (en) | Organic compounds and their uses | |
MX2010001692A (es) | Ciertas entidades quimicas, composiciones y metodos. | |
BR112014019399A2 (pt) | métodos de tratamento da fibrose | |
WO2009080800A3 (en) | Method for decreasing abdominal girth by administering a bifidobacterium bacteria | |
MX2015006120A (es) | Compuestos novedosos oralmente biodisponibles que modulan el control de la respiracion, y metodos de uso de los mismos. | |
MX2009005725A (es) | Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13. | |
MX2017015012A (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
UA118339C2 (uk) | Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти) | |
BR112012009121A2 (pt) | Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |